Long-term impact of angiotensin receptor-neprilysin inhibitor based on short-term treatment response in heart failure.

Hyuk Kyoon ParkJong Sung ParkMyeong Seop KimEunkyu LeeHyohun ChoiYoon Jung ParkBo Eun ParkHong Nyun KimNam Kyun KimMyung Hwan BaeJang Hoon LeeHun Sik ParkYongkeun ChoSe Yong JangDong Heon Yang

Published in: ESC heart failure (2023)

Regardless of significant treatment response measured by either LVEF or LV reverse remodelling after 1 year of treatment, the extended utilization of ARNI demonstrated a more favourable prognosis than that of ACEIs/ARBs in patients with HFrEF.

Keyphrases

heart failure
angiotensin ii
left ventricular
combination therapy
binding protein
replacement therapy
smoking cessation